dapsone has been researched along with Diabetes Mellitus, Type 2 in 12 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with dapsone and etretinate was reasonably effective, but etretinate had to be discontinued due to the development of diffuse idiopathic skeletal hyperostosis." | 1.28 | Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA. ( Bingham, EA; Burrows, D; Todd, DJ; Walsh, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hioki, T | 1 |
| Araki, M | 1 |
| Kamiya, H | 1 |
| Kitajima, Y | 1 |
| Ram, N | 1 |
| Rashid, MO | 1 |
| Farooq, S | 1 |
| Cheng, WC | 1 |
| Lo, SC | 1 |
| Wu, KR | 1 |
| Lee, LN | 1 |
| Shah, AD | 1 |
| Fox, RK | 1 |
| Rushakoff, RJ | 1 |
| Goucha, S | 1 |
| Khaled, A | 1 |
| Kharfi, M | 1 |
| Fazaa, B | 1 |
| Zermani, R | 1 |
| Ben Jilani, S | 1 |
| Kamoun, MR | 1 |
| Rushing, EC | 1 |
| Hoschar, AP | 1 |
| McDonnell, JK | 1 |
| Billings, SD | 1 |
| Khan, F | 1 |
| Chan, CS | 1 |
| LeLeux, TM | 1 |
| Diwan, AH | 1 |
| Hsu, S | 1 |
| Lai, YC | 1 |
| Wang, CS | 1 |
| Wang, YC | 1 |
| Hsu, YL | 1 |
| Chuang, LM | 1 |
| Roxby, A | 1 |
| Jain, R | 1 |
| Serwin, AB | 1 |
| Myśliwiec, H | 1 |
| Laudańska, H | 1 |
| Chodynicka, B | 1 |
| Bauwens, M | 1 |
| De Coninck, A | 1 |
| Roseeuw, D | 1 |
| Todd, DJ | 1 |
| Bingham, EA | 1 |
| Walsh, M | 1 |
| Burrows, D | 1 |
1 review available for dapsone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Subcorneal pustular dermatosis treated with PUVA therapy. A case report and review of the literature.
Topics: Dapsone; Diabetes Mellitus, Type 2; Humans; Male; Middle Aged; PUVA Therapy; Skin Diseases, Vesiculo | 1999 |
11 other studies available for dapsone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Annular elastolytic giant cell granuloma associated with diabetes mellitus: a case treated with a combination of low-dose cyclosporine and dapsone.
Topics: Aged, 80 and over; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Diabetes Melli | 2019 |
Spuriously Low HbA1C Levels in a Type II Diabetes Patient Taking Dapsone.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Dapsone; Diabetes Mellitus, Type 2; False Ne | 2017 |
Causes of decreased HbA1c levels in a medical center laboratory in Taiwan.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Hu | 2013 |
Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone.
Topics: Blood Glucose; Dapsone; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans | 2014 |
Granuloma annulare.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Antirh | 2008 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clo | 2011 |
JAAD Grand Rounds quiz. Adult with red-brown nodules and plaques.
Topics: Biopsy, Needle; Celiac Disease; Dapsone; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hyper | 2011 |
Falsely decreased HbA1c in a type 2 diabetic patient treated with dapsone.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Dapsone; Diabetes Mellitus, Type 2; Glycated He | 2012 |
Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient.
Topics: Blood Glucose; Burkitt Lymphoma; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Dapsone | 2013 |
Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Diabetes Mellitus, Type 2; Drug Therapy, C | 2002 |
Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA.
Topics: Aged; Dapsone; Diabetes Mellitus, Type 2; Etretinate; Humans; Immunoglobulin A; Male; Paraproteinemi | 1991 |